Tolerance of efavirenz in children

被引:32
作者
Teglas, JP
Quartier, P
Treluyer, JM
Burgard, M
Gregoire, V
Blanche, S
机构
[1] Hop Necker Enfants Malad, Unite Immunol Hematol Pediat, F-75743 Paris 15, France
[2] Hop Bicetre, INSERM U292, Bicetre, France
[3] Hop St Vincent de Paul, Pharmacol Lab, F-75674 Paris, France
[4] Hop Necker Enfants Malad, Virol Lab, F-75743 Paris 15, France
[5] DuPont Pharma, Paris, France
关键词
HIV; children; treatment; non-nucleoside reverse transcriptase inhibitor; efavirenz;
D O I
10.1097/00002030-200101260-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To extend the limited knowledge of efavirenz tolerance in children. Method: An observational study of 33 children given efavirenz combined with various others agents and followed in a single institution. Results: Fifteen (42%) of the children presented at least one clinically discernable side effect, cutaneous (n = 5), nervous system (n = 10), or both (n = 2). Intolerance led to treatment interruption in seven children but the main symptom was transitory dizziness or other signs similar to those observed in adults. Conclusion: Early, often transient nervous system side effects require careful preparation with the child and his family to avoid premature and inadequate withdrawal from treatment. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:241 / 243
页数:3
相关论文
共 9 条
[1]  
[Anonymous], 1994, MMWR Recomm Rep, V43, P1
[2]  
[Anonymous], 2008, Guidelines for the Use of Antiretroviral Agents in HIV-1- Infected adults and Adolescents
[3]  
Harris M, 2000, REV MED VIROL, V10, P217, DOI 10.1002/1099-1654(200007/08)10:4&lt
[4]  
217::AID-RMV279&gt
[5]  
3.0.CO
[6]  
2-L
[7]   Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection [J].
Luzuriaga, K ;
Bryson, Y ;
Krogstad, P ;
Robinson, J ;
Stechenberg, B ;
Lamson, M ;
Cort, S ;
Sullivan, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (19) :1343-1349
[8]   Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1 [J].
Starr, SE ;
Fletcher, CV ;
Spector, SA ;
Yong, FH ;
Fenton, T ;
Brundage, RC ;
Manion, D ;
Ruiz, NM ;
Gersten, M ;
Becker, M ;
McNamara, J ;
Mofenson, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1874-1881
[9]  
*WHO, 1990, WKLY EPIDEMIOL REC, V65, P221